- Home
- OBIO vs PLL Comparison
OBIO vs PLL Comparison
Compare OBIO & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PLL
- Stock Information
- Founded
- OBIO 2017
- PLL 2016
- Country
- OBIO United States
- PLL United States
- Employees
- OBIO N/A
- PLL N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PLL Other Metals and Minerals
- Sector
- OBIO Health Care
- PLL Basic Materials
- Exchange
- OBIO Nasdaq
- PLL Nasdaq
- Market Cap
- OBIO 200.1M
- PLL 230.6M
- IPO Year
- OBIO N/A
- PLL 2017
- Fundamental
- Price
- OBIO $4.88
- PLL $9.76
- Analyst Decision
- OBIO Strong Buy
- PLL Buy
- Analyst Count
- OBIO 4
- PLL 9
- Target Price
- OBIO $15.75
- PLL $22.04
- AVG Volume (30 Days)
- OBIO 53.8K
- PLL 589.0K
- Earning Date
- OBIO 11-12-2024
- PLL 11-12-2024
- Dividend Yield
- OBIO N/A
- PLL N/A
- EPS Growth
- OBIO N/A
- PLL N/A
- EPS
- OBIO N/A
- PLL N/A
- Revenue
- OBIO $2,647,000.00
- PLL $46,981,000.00
- Revenue This Year
- OBIO $12.39
- PLL $133.73
- Revenue Next Year
- OBIO $120.99
- PLL $30.30
- P/E Ratio
- OBIO N/A
- PLL N/A
- Revenue Growth
- OBIO N/A
- PLL N/A
- 52 Week Low
- OBIO $4.22
- PLL $6.57
- 52 Week High
- OBIO $10.46
- PLL $31.82
- Technical
- Relative Strength Index (RSI)
- OBIO 43.91
- PLL 33.85
- Support Level
- OBIO $4.78
- PLL $10.22
- Resistance Level
- OBIO $5.84
- PLL $13.07
- Average True Range (ATR)
- OBIO 0.42
- PLL 0.71
- MACD
- OBIO -0.04
- PLL -0.30
- Stochastic Oscillator
- OBIO 24.24
- PLL 0.00
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PLL Piedmont Lithium Inc.
Piedmont Lithium Inc, is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and world-wide energy security. Its portfolio of wholly-owned projects includes Carolina Lithium, a proposed fully integrated spodumene ore-to-lithium hydroxide project in Gaston County, North Carolina, and Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee.